PLUS1
Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Nymox Pharmaceutical Corp. | NYMX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0 | +0% | 4.19 | 4.19 | 4.1 | 4.18 | 4.19 | 10:54:32 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.18 | 4.19 | 0.01 | 0.24% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 54 | 9,294 | $ 4.1550 | $ 38.62k | 177.19k | 3.00 - 5.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:01:51 | 200 | $4.19 | USD |
Nymox Pharmaceutical Corp. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 239.7M | 57.21M | $ -13.43M | -0.26 | 0.00 | 32.69M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | 78k | 6.20% |
Nymox Pharmaceutical Corp. News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/12/2018 | 09:45 | GlobeNewswire Inc. | Nymox Announces $16.25 Million Equity Financing With.. |
| 4/10/2018 | 10:00 | GlobeNewswire Inc. | New Online Commentary in UroToday on Fexapotide BPH Clinical.. |
| 3/30/2018 | 10:45 | Edgar (US Regulatory) | Annual and Transition Report (foreign Private Issuer) (20-f) |
| 3/27/2018 | 16:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/22/2018 | 17:57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/16/2018 | 10:50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/12/2018 | 14:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NYMX Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 4.14 | 4.43 | 4.02 | 4.2356 | 71k | 223k | 119k | 0.05 | 1.21% |
| 1 Month | 3.98 | 4.6 | 3.9 | 4.2344 | 41k | 401k | 124k | 0.21 | 5.28% |
| 3 Months | 3.37 | 4.6 | 3.1 | 3.7262 | 36k | 401k | 137k | 0.82 | 24.33% |
| 6 Months | 3.85 | 4.6 | 3 | 3.6029 | 18k | 3M | 137k | 0.34 | 8.83% |
| 1 Year | 4.46 | 5.1 | 3 | 3.8193 | 18k | 3M | 154k | -0.27 | -6.05% |
| 3 Years | 1.4 | 5.79 | 1.13 | 3.1561 | 14k | 28M | 390k | 2.79 | 199.29% |
| 5 Years | 4.9 | 8.19 | 0.32 | 2.6803 | 6k | 28M | 362k | -0.71 | -14.49% |
Nymox Pharmaceutical Corp. Description
| Nymox Pharmaceutical Corporation is a biopharmaceutical company, engaged in R&D & sale of drugs for the aging population. It offers products such as AlzheimAlert™, NicAlert™ & TobacAlert™ & is developing NX-1207 for benign prostatic hyperplasia. |
